← All organizations
Chong Kun Dang Pharmaceutical
For profitWebsite ↗
Also known as: Chong Kun Dang pharm | Chong Kun Dang Pharm. | Chong Kun Dang Pharmaceutical | Chong Kun Dang Pharmaceutical Company | Chong Kun Dang Pharmaceutical Corp. | CKD Pharmaceutical Limited | Seoul, Gwanak-gu, South Korea, 08779 | yangch@catholic.ac.kr
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2007Last known activity
Oct 31, 2025
Timeline
1940s
- Jan 1, 1941
Chong Kun Dang Pharmaceutical— Founded
Drugs by trial phase (140 distinct, 302 trials)
Phase 4 (31 own, 0 via acquisition)
Phase 3 (33 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (51 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alzheimer Disease
- Anemia
- Angina, Stable
- Arthritis
- Arthritis, Rheumatoid
- Aspergillosis
- Atrial Fibrillation
- Candidiasis
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Small Cell
- Carcinoma, Transitional Cell
- Cardiovascular Diseases
- Central Nervous System Diseases
- Colorectal Neoplasms
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dry Eye Syndromes
- Dyslipidemias
- Esophagitis
- Esophagitis, Peptic
- Essential Hypertension
- Eye Diseases
- Gastritis
- Gastroesophageal Reflux
- Gastrointestinal Stromal Tumors
- Glaucoma
- Glaucoma, Open-Angle
- Glomerulonephritis, IGA
- Heart Diseases
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Huntington Disease
- Hypercholesterolemia
- Hyperlipidemia, Familial Combined
- Hyperlipidemias
- Hyperplasia
- Hypertension
- Hypogonadism
- Infections
- Keratoconjunctivitis Sicca
- Kidney Diseases
- Leiomyosarcoma
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Liver Diseases
- Lung Neoplasms
- Lymphoma
- Multiple Myeloma
- Mycoses
- Myocardial Ischemia
- Neoplasms
- Neoplasms, Plasma Cell
- Nephrosis
- Nephrotic Syndrome
- Nervous System Diseases
- Ocular Hypertension
- Osteoarthritis
- Osteoarthritis, Knee
- Ovarian Neoplasms
- Pneumonia
- Premature Birth
- Prostatic Hyperplasia
- Recurrence
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Tract Infections
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Small Cell Lung Carcinoma
- Syndrome
- Tachycardia
- Tachycardia, Ventricular
- Tricuspid Valve Insufficiency
- Ventricular Premature Complexes
Recent trials (50)
- NCT07215637Lead sponsorPhase 1Oct 31, 2025
- NCT07304726Lead sponsorPhase 1Oct 30, 2025
- NCT07304700Lead sponsorPhase 1Oct 28, 2025
- NCT07304687Lead sponsorPhase 1Oct 24, 2025
- NCT06942156Lead sponsorPhase 4Aug 14, 2025
- NCT06979973Lead sponsorPhase 1May 14, 2025
- NCT06954766Lead sponsorPhase 2May 12, 2025
- NCT06916793Lead sponsorPhase 3Apr 30, 2025
- NCT06758661Lead sponsorPhase 1Nov 27, 2024
- NCT06727396Lead sponsorPhase 1Nov 14, 2024
- NCT06709807Lead sponsorPhase 1Nov 8, 2024
- NCT06695572Lead sponsorPhase 1Nov 6, 2024
- NCT06695598Lead sponsorPhase 1Nov 6, 2024
- NCT06652971Lead sponsorPhase 1Nov 5, 2024
- NCT06492655Lead sponsorPhase 1Jul 4, 2024
Details
- Founded
- Seoul, KR Jan 1, 1941
- Last known activity
- Oct 31, 2025